文献速递心律失常

植入式心律转复除颤器治疗中性别差异与心律失常检测时间的关系

Sex differences in implantable cardiac defibrillator therapy according to arrhythmia detection times.
PubMed 文献 · Heart · 2019-12-11

本研究为Advance III试验的事后分析,纳入1902例植入ICD的患者(女性304例),随机分为长检测时间组(NID 30/40)和常规检测时间组(NID 18/24)。主要终点为ICD治疗发生率。结果显示女性ICD治疗风险低于男性(HR 0.63),该差异仅见于长检测时间组;长检测设置显著减少女性和男性的总体及适当ICD治疗,且女性减少幅度更大。

要点

  • 长检测时间(NID 30/40)较常规设置(NID 18/24)减少ICD总体治疗,女性与男性均获益。
  • 女性ICD治疗风险低于男性,但该差异仅在长检测时间组中显著。
  • 不适当治疗与死亡率未见显著性别差异。

核心结论

  • 长检测时间设置(NID 30/40)较常规设置(NID 18/24)减少ICD总体治疗,女性与男性均获益,且女性减少幅度更大。
  • 女性ICD治疗风险低于男性,该差异仅在长检测时间组中观察到。

研究设计与样本

  • Advance III试验的事后分析,随机对照研究,纳入1902例植入ICD进行一级或二级预防的患者(女性304例,年龄65±11岁)。
  • 患者随机分为长检测时间组(NID 30/40)和常规检测时间组(NID 18/24)。

主要发现

  • 女性ICD治疗风险低于男性(HR 0.63,95%CI 0.43-0.93,p=0.022)。
  • 该性别差异仅见于长检测时间组(HR 0.37,p=0.013),常规检测时间组未见(HR 0.82,p=0.414)。
  • 不适当治疗和死亡率未见显著性别差异。
  • 长检测设置显著减少女性总体ICD治疗(HR 0.31,p=0.007)和适当ICD治疗(HR 0.33,p=0.033)。
  • 长检测设置显著减少男性总体ICD治疗(HR 0.69,p=0.006)和适当ICD治疗(HR 0.73,p=0.048)。

关键数值与推荐

  • 长检测时间设置NID 30/40,常规检测时间设置NID 18/24。

临床怎么用

  • 对于植入ICD的患者,采用长检测时间设置(NID 30/40)可减少总体ICD治疗,女性与男性均获益。
  • 女性在接受长检测时间设置时ICD治疗风险显著低于男性,临床可考虑个体化检测设置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In implantable cardiac defibrillators (ICDs), long-detection times safely reduce unnecessary and inappropriate therapies. We aimed to evaluate ICD treatment of ventricular arrhythmias in women, compared with men, also taking into account ICD detection. METHODS: The Advance III trial randomised patients implanted with an ICD for primary or secondary prevention in two arms-long and nominal ventricular arrhythmias detection times before therapy delivering (number of intervals needed to detect (NID) 30/40 and 18/24, respectively). The main endpoint of this post hoc analysis was the incidence of ICD therapies evaluated through Kaplan-Meier method and univariate Cox regression models. RESULTS: Overall, 1902 patients (304 women, 65±11 years) were randomised. Women showed a lower risk of ICD therapy (HR 0.63, 95% CI 0.43 to 0.93, p=0.022); this difference was observed only in the long-detection arm (HR 0.37, p=0.013) and not in the short detection arm (HR 0.82, p=0.414). No significant sex differences were observed concerning inappropriate therapies and mortality rate. Long-detection settings significantly reduced overall ICD therapies and appropriate ICD therapies, both in women (overall HR 0.31, p=0.007; appropriate HR 0.33, p=0.033) and in men (overall HR 0.69, p=0.006; appropriate HR 0.73, p=0.048). CONCLUSIONS: In patients with ICDs, the strategy of setting a long-detection time to treat ventricular arrhythmias (NID 30/40) reduces overall delivered therapies, both in women and men, when compared with nominal setting (NID 18/24). The reduction was significantly higher in women. Overall, women were less likely to experience ICD therapies than men; this result was only observed in the long-detection arm. CLINICAL TRIAL REGISTRATION: NCT00617175.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Gasparini M, Kloppe A, Lunati M, et al. Sex differences in implantable cardiac defibrillator therapy according to arrhythmia detection times. Heart. 2019. PMID: 31826936. doi:10.1136/heartjnl-2019-315650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。